537P-SC Exposure-response analysis of cabozantinib in patients with metastatic renal cell cancer treated in routine care

Authors :: Sasja F. Mulder
Stefanie L. Groenland
C.M.L. van Herpen
Dirk Jan A.R. Moes
N. P. van Erp
T. van der Hulle
Stefanie D. Krens
Ingrid M.E. Desar
Neeltje Steeghs
Source :: Annals of Oncology. 32:S602
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Oncology
medicine.medical_specialty
Cabozantinib
business.industry
Hematology
chemistry.chemical_compound
chemistry
Internal medicine
Medicine
In patient
Metastatic renal cell cancer
business
Routine care
Exposure response

Tools